KOL | John A EllertonFrom Mountain Rescue (England and Wales), Cumbria, England (Dr Ellerton); the Eye Clinic, University Hospital, Croatian Mountain Rescue Service, Split, Croatia (Dr Zuljan); ... |
KOL Resume for John A Ellerton
| Year | |
|---|---|
| 2009 | From Mountain Rescue (England and Wales), Cumbria, England (Dr Ellerton); the Eye Clinic, University Hospital, Croatian Mountain Rescue Service, Split, Croatia (Dr Zuljan); the Italian Alpine Club Medical Commission, Colzate, Italy (Dr Agazzi); and the Emergency Department, Mineral Springs, Banff, Alberta, Canada (Dr Boyd) |
| 2000 | From the Division of Medicine, The University of Texas M. D. Anderson Cancer Center (P.M.H., R.J.W., J.L.A.), Houston, Texas; Southern Nevada Community Clinical Oncology Program (J.A.E.), Las Vegas, Nevada; and Wichita Community Clinical Oncology Program (S.R.D.), Wichita, Kansas; Division of Oncology Drug Products, Food and Drug Administration (R.P.), Rockville, Maryland. |
| 1979 | Department of Medicine, Toronto Western Hospital, University of Toronto, Toronto, Canada |
John A Ellerton: Influence Statistics
| Concept | World rank |
|---|---|
| snow blindness | #6 |
| kidney transplantation leukemia | #12 |
| snow ultraviolet | #31 |
| antibodies pertuzumab | #46 |
| treatment tdm1 | #67 |
| immunoconjugates antineoplastic | #74 |
| trial dm1 | #77 |
Open the FULL List in Excel | |
Prominent publications by John A Ellerton
BACKGROUND: CLEOPATRA was a phase 3 study comparing the efficacy and safety of pertuzumab, trastuzumab, and docetaxel with placebo, trastuzumab, and docetaxel in patients with HER2-positive metastatic breast cancer. In the primary analysis and subsequent reports, progression-free and overall survival were significantly improved in the pertuzumab group compared with the placebo group. Here, we report the end-of-study analysis of CLEOPATRA.
METHODS: This was a double-blind, randomised, ...
| Known for Pertuzumab Trastuzumab | Metastatic Breast | 3 Study | Docetaxel Patients | Clinical Cutoff |
Although eyes are not frequently injured in the mountains, they are exposed to many adverse factors from the environment. This article, intended for first responders, paramedics, physicians, and mountaineers, is the consensus opinion of the International Commission for Mountain Emergency Medicine (ICAR-MEDCOM). Its aim is to give practical advice on the management of eye problems in mountainous and remote areas. Snow blindness and minor injuries, such as conjunctival and corneal foreign ...
| Known for Eye Problems | Snow Blindness | Contact Lenses | Ultraviolet Light | Devices Humans |
A 53-year-old male developed acute erythroleukemia three years after renal transplantation. He had received three years of immunosuppressive therapy with azathioprine. A preleukemia phase associated with chromosome abnormalities was recognized. Azathioprine has been associated with chromosome abnormalities. The chronic stimulation of an abnormal erythroid clone by transplantation may have hastened the development of erythroleukemia.
| Known for Chromosome Abnormalities | Renal Transplantation | Acute Male | Humans Kidney | Leukemia Erythroblastic |
Key People For Systemic Therapy
John A Ellerton:Expert Impact
Concepts for whichJohn A Ellertonhas direct influence:Systemic therapy, Trastuzumab pertuzumab, Pertuzumab trastuzumab, Chemotherapy patients, Patients atezolizumab, Phase iii trial, Trastuzumab taxane, Capecitabine patients.
John A Ellerton:KOL impact
Concepts related to the work of other authors for whichfor which John A Ellerton has influence:Positive breast, Trastuzumab deruxtecan, Hormone receptor, Patients her2, Brain metastases, Systemic therapy, Low vision.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |